Cost-effectiveness of idelalisib in combination with rituximab for the treatment of relapsed/refractory chronic lymphocytic leukemia (Cll) in Portugal

M. Gouveia, M. G. Silva, J. Alarcão, F. Fiorentino, J. Carda, R. Costa, J. M. Mariz, J. Raposo, J. Costa, M. Borges

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberPCN180
Pages (from-to)A461-A462
Number of pages2
JournalValue in Health
Volume18
Issue number7
DOIs
Publication statusPublished - 1 Nov 2015

Cite this